Showing results (141-150 of 6,842) with videos related to
Sort By:
Pageof 685
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force reportLouis P Garrison, Peter J Neumann, Pennifer Erickson, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 25, 2022
Toward comprehensive value assessment for Alzheimer's disease innovationsPhyllis B Ferrell, Howard Fillit, Peter J Neumann, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 9, 2017
Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's diseasePei-Jung Lin, Yue Zhong, Howard M Fillit, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Cost-utility analyses in diabetes: a systematic review and implications from real-world evidenceYue Zhong, Pei-Jung Lin, Joshua T Cohen, et al.Health Affairs Scholar|April 22, 2026
Cost-effectiveness thresholds used in the United States vs most favored nationsHanxuan Yu, Peter J Neumann, David D Kim, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 3, 2005
Quality of abstracts of papers reporting original cost-effectiveness analysesAllison B Rosen, Dan Greenberg, Patricia W Stone, et al.Expert Review of Pharmacoeconomics & Outcomes Research|October 20, 2015
The peculiar economics of life-extending therapies: a review of costing methods in health economic evaluations in oncologyNatalia Olchanski, Yue Zhong, Joshua T Cohen, et al.Journal of the American College of Radiology : JACR|December 3, 2019
Cost-Effectiveness Analysis in Pediatric Imaging: The Evidence (or Lack Thereof) Thus FarHansel J Otero, Andrew J Degnan, Nadja Kadom, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 20, 2010
How long and how well: oncologists' attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatmentsMichael A Kozminski, Peter J Neumann, Eric S Nadler, et al.International Journal of Technology Assessment in Health Care|April 29, 2020
Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?Xue Feng, David D Kim, Joshua T Cohen, et al.Pageof 685